News

Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD)’s stock, assigning a “Buy” rating with the price ...
Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...
Growing up in the Sanders household means cameras are always rolling and competition never takes a day off. From Coach Prime's press conferences to Shilo's monthly sibling rankings ...
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand ...
Endocrinologist with NL Health Services, Dr. Zaina Albalawi, says continuous blood sugar monitoring is the standard of care ...
The global insulin pumps market, valued at USD 5.5 billion in 2022, is poised for remarkable growth, with an anticipated compound annual growth rate (CAGR) of 10.3% from 2022 to 2032, according to a ...
Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1 MANCHESTER, N.H., ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Global Insulin Pumps Market ...
In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.
Besides the traditional tubed pumps, an insulin patch pump known as Omnipod is also available. This small tubeless pump adheres directly to your skin without tubing. Innovations in pump technology ...
Omnipod 5 is designed to make living with diabetes simpler, delivering exceptional ease of use; it automatically manages glucose levels, eliminating multiple daily injections, insulin pump tubing ...
Omnipod 5 is designed to make living with diabetes simpler, delivering exceptional ease of use; it automatically manages glucose levels, eliminating multiple daily injections, insulin pump tubing or ...